Insulin Therapy of Diabetes with Implantable Infusion Pumps: Clinical Aspects

The DCCT Research Group: the diabetes control and complications trial (DCCT): results of feasibility study. Diabetes Care 1987; 10: 1–119.

Skyler J.S. Complications of diabetes mellitus: relationship to metabolic dysfunction. Diabetes Care 1979; 2: 499–509.

Skyler J.S. Continuous subcutaneous insulin infusion (CSII) with external devices: current status. In: Ensminger W.D. , Selam J.L. , eds. Update in Drug Delivery Systems, Mount Kisco N.Y.: Futura Publishing Co. 1989; 163–85.

Selam J.L. , Charles M.A. Devices for insulin administration. Diab Met Rev (in press).

Stolar M.W. Atherosclerosis in diabetes: the role of hyperinsulinemia. Metabolism 1988; 37: 1–9.

Stout R.W. Blood glucose and atherosclerosis. Atherosclerosis 1981; 1: 227.

Reach G. Closed loop insulin delivery systems: the biological approach. In: Ensminger W.D. , Selam J.L. , eds. Update in Drug Delivery Systems, Mount Kisco, N.Y: Futura Publishing Co. 1989; 163–85.

Dubernard J.M. , Sutherland D.E.R. Perspective in pancreatic transplantation. In: International handbook of pancreas transplantation. Dubernard J.M. , Sutherland D.E.R. , eds. Netherlands: Kluwer Acad Publ, 1989; 519–30.

Selam J.L. The need for a development strategy on implantable pumps in type I diabetes. In: Ensminger W.D. , Selam J.L. , eds. Update in Drug Delivery Systems, Mount Kisco N.Y.: Futura Publishing Co. 1989; 163–85.

Blackshear P.J. , Dorman F.D. , Blackshear P.L. Jr. . Permanently implantable, self-recycling, low-flow, constant-rate, multi-purpose infusion pump of simple design. Surgical Form 1970; 21: 136.

Slama G. , Hautecouverture M. , Assan R. , Tchobroutsky G. One to five days of continuous intravenous insulin infusion on seven diabetic patients. Diabetes 1974; 23: 732–8.

Pickup J.C. , Keen H. , Parsons J.A. , Alberti KGMM . Continuous subcutaneous insulin infusion: an approach to achieving normoglycemia. Br Med J 1978; i: 204–7.

Irsigler K. , Kritz H. , Hagmueller A. Long-term continuous intraperitoneal insulin infusion with an implanted remote-controlled insulin device. Diabetes 1981; 30: 1072–4.

Selam J.L. , Slingeneyer A. , Chaptal P.A. , Franetzki M. , Perstele K. , Mirouze J. Total implantation of remotely controlled insulin minipump in a human insulin-dependent diabetic. Artif Organs 1982; 6: 315–9.

Buchwald H. , Varco R. , Rupp W.M. Treatment of a type II diabetic by a totally implantable insulin device. Lancet 1981; i: 1233.

Kritz H. , Hagmuller G. , Lovett R. , Irsigler K. Implanted constant basal rate insulin infusion devices for type I development diabetic patients. Diabetologia 1983; 25: 78–81.

Selam J.L. Development of implantable insulin pumps: current italics. In: Ensminger W.D. , Selam J.L. , eds. Update in Drug Delivery Systems. Mount Kisco, NY: Futura Publishing Co. Inc. 1989; 83–103.

Saudek C.D. , Selam J.L. , Pitt H.A. A feasability trial with the programmable implantable medication system for insulin delivery. N Engl J Med 1989; 321: 574–9.

Point Study Group: one year trial of remote-controlled implantable insulin infusion system in type I diabetic patients. Lancet 1988; 864–9.

Selam J.L. , Raccah D. , Jean-Didier N. A randomized controlled efficacy evaluation of insulin therapy with implantable programmable pumps (submitted).

Knatterud G. , Fisher M. International Study Group on Implantable Delivery Devices Registry. Diab Nutr Met 1988; 323–38.

Knatterud G. , Fisher M. , Selam J.L. 1989 ISGIID Registry Update. ISGIID Newsletter 1989.

Selam J.L. Development of implantable insulin pumps: long is the road. Diab Medicine 1988; 5: 724–33.

Irsigler K. , Hutter R. , Kritz H. Comparative evaluation of long-term treatment with implanted and external insulin infusion devices (1981–88) Diab Nut Metab (in press).

Schade D.S. , Eaton P. , Davis T. The kinetics of peritoneal insulin absorption. Metabolism 1981; 30: 149–55.

Nelson J.A. , Stephen R. , Landou S.T. , Wilson D.E. , Tyler F.H. Intraperitoneal insulin administration produces a positive portal-systemic blood insulin gradient in unanesthetized swine. Metabolism 1982; 31: 969–72.

Kernistine K.H. , Rhode T.D. , Wigness B.D. Is intraperitoneal insulin delivery more physiologic than intravenous delivery? Diab Nutr Metab (in press).

Radziuk J. , Pye S. , Davies G. , Seigler D. , Reeves M. Splanchnic and systemic absorption of intraperitoneal insulin. Diabetes Research and Clinical Practice 1988; 5(supp 11): 24.

Selam J.L. , Bergman R.N. , Raccah D. , Jean Didier N. , Lozano J. , Charles M.A. Determination of portal insulin absorption from peritoneum using a novel non-invasive non-isotopic method. Diabetologia Suppl 1989; 32: 540.

Volund A. , Polonsky K.S. Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics. Diabetes 1987; 36: 1195–202.